{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:35:58Z","timestamp":1774956958125,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bbadis.2022.166369","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T22:18:44Z","timestamp":1644877124000},"page":"166369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Myeloid differential protein-2 inhibition improves diabetic cardiomyopathy via p38MAPK inhibition and AMPK pathway activation"],"prefix":"10.1016","volume":"1868","author":[{"given":"Jianchang","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr V.","family":"Samorodov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin N.","family":"Pavlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2022.166369_bb0005","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/CIRCRESAHA.118.314665","article-title":"Diabetic cardiomyopathy","volume":"124","author":"Dillmann","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2022.166369_bb0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cardfail.2014.02.007","article-title":"The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota","volume":"20","author":"Dandamudi","year":"2014","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.bbadis.2022.166369_bb0015","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","volume":"140","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2022.166369_bb0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2003.11.024","article-title":"Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure","volume":"43","author":"Gustafsson","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.bbadis.2022.166369_bb0025","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2022.166369_bb0030","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tem.2020.07.001","article-title":"Metabolism-associated molecular patterns (MAMPs)","volume":"31","author":"Wang","year":"2020","journal-title":"Trends in endocrinology and metabolism: TEM"},{"key":"10.1016\/j.bbadis.2022.166369_bb0035","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/med.21711","article-title":"Pattern recognition receptor-mediated inflammation in diabetic vascular complications","volume":"40","author":"Wang","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbadis.2022.166369_bb0040","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2022.166369_bb0045","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s13300-020-00802-4","article-title":"Systemic delivery of siRNA specific for silencing TLR4 gene expression reduces diabetic cardiomyopathy in a mouse model of streptozotocin-induced type 1 diabetes","volume":"11","author":"Zhang","year":"2020","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.bbadis.2022.166369_bb0050","first-page":"585","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"nature reviewsCardiology"},{"key":"10.1016\/j.bbadis.2022.166369_bb0055","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41467-020-15978-3","article-title":"MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2022.166369_bb0060","doi-asserted-by":"crossref","first-page":"13997","DOI":"10.1038\/ncomms13997","article-title":"Saturated palmitic acid induces myocardial inflammatory injuries through direct binding to TLR4 accessory protein MD2","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2022.166369_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev. Endocrinol. Metab. Disord."},{"key":"10.1016\/j.bbadis.2022.166369_bb0070","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002562R","article-title":"Cell death-inducing DFFA-like effector C\/CIDEC gene silencing alleviates diabetic cardiomyopathy via upregulating AMPKa phosphorylation","volume":"35","author":"Zhou","year":"2021","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2022.166369_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115533","article-title":"Cinacalcet as a surrogate therapy for diabetic cardiomyopathy in rats through AMPK-mediated promotion of mitochondrial and autophagic function","volume":"421","author":"Elrashidy","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/1440-1681.12194","article-title":"Advanced glycation end-products impair Na(+)\/K(+)-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase\/sirtuin 1 pathway","volume":"41","author":"Yuan","year":"2014","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0085","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2337\/db10-0351","article-title":"Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice","volume":"60","author":"Xie","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2022.166369_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.634900","article-title":"Combined Administration of Metformin and Atorvastatin Attenuates Diabetic Cardiomyopathy by inhibiting inflammation, apoptosis, and oxidative stress in type 2 diabetic mice","volume":"9","author":"Jia","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1475-2840-8-16","article-title":"Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model\u2013the zucker diabetic rat","volume":"8","author":"Forcheron","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0100","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7150\/ijbs.29680","article-title":"Metformin inhibits the NLRP3 inflammasome via AMPK\/mTOR-dependent effects in diabetic cardiomyopathy","volume":"15","author":"Yang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbadis.2022.166369_bb0105","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jcp.22093","article-title":"Curcumin stimulates glucose uptake through AMPK-p38 MAPK pathways in L6 myotube cells","volume":"223","author":"Kim","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0110","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.bbagen.2006.09.007","article-title":"Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK","volume":"1760","author":"Cheng","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2022.166369_bb0115","doi-asserted-by":"crossref","first-page":"8110","DOI":"10.1021\/jm200946h","article-title":"Evaluation and discovery of novel synthetic chalcone derivatives as anti-inflammatory agents","volume":"54","author":"Wu","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2022.166369_bb0120","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1111\/bph.13221","article-title":"MD-2 as the target of a novel small molecule, L6H21, in the attenuation of LPS-induced inflammatory response and sepsis","volume":"172","author":"Wang","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0125","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12918-016-0359-z","article-title":"An improved method for functional similarity analysis of genes based on gene ontology","volume":"10","author":"Tian","year":"2016","journal-title":"BMC Syst. Biol."},{"issue":"21","key":"10.1016\/j.bbadis.2022.166369_bb0135","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1093\/bioinformatics\/btaa658","article-title":"Differential gene set enrichment analysis: a statistical approach to quantify the relative enrichment of two gene sets","volume":"36","author":"Joly","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbadis.2022.166369_bb0140","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1111\/bph.14687","article-title":"Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys","volume":"176","author":"Wang","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.bbadis.2022.166369_bb0150","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166369_bb0155","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/infdis\/jiq155","article-title":"MD-2 as the target of nonlipid chalcone in the inhibition of endotoxin LPS-induced TLR4 activity","volume":"203","author":"Roh","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbadis.2022.166369_bb0160","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1189\/jlb.1206727","article-title":"MD-2 as the target of curcumin in the inhibition of response to LPS","volume":"82","author":"Gradisar","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0165","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1055\/s-0029-1241013","article-title":"Xanthohumol and related prenylated flavonoids inhibit inflammatory cytokine production in LPS-activated THP-1 monocytes: structure-activity relationships and in silico binding to myeloid differentiation protein-2 (MD-2)","volume":"76","author":"Peluso","year":"2010","journal-title":"Planta Med"},{"key":"10.1016\/j.bbadis.2022.166369_bb0170","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1111\/bph.12091","article-title":"Suppression of toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2","volume":"168","author":"Kim","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2022.166369_bb0180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yjmcc.2014.09.022","article-title":"Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1\/AMPK pathway","volume":"77","author":"Zhang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2022.166369_bb0185","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4161\/auto.7.10.16740","article-title":"AMP-activated protein kinase modulates cardiac autophagy in diabetic cardiomyopathy","volume":"7","author":"Xie","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2022.166369_bb0190","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4161\/auto.23577","article-title":"Regulation of interplay between autophagy and apoptosis in the diabetic heart: new role of AMPK","volume":"9","author":"Zou","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.bbadis.2022.166369_bb0195","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1074\/jbc.271.17.10282","article-title":"Characterization of AMP-activated protein kinase beta and gamma subunitsAssembly of the heterotrimeric complex in vitro","volume":"271","author":"Woods","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbadis.2022.166369_bb0200","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09932","article-title":"Structure of mammalian AMPK and its regulation by ADP","volume":"472","author":"Xiao","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2022.166369_bb0205","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCRESAHA.116.309937","article-title":"AMP-activated protein kinase alpha2 in neutrophils regulates vascular repair via hypoxia-inducible factor-1alpha and a network of proteins affecting metabolism and apoptosis","volume":"120","author":"Abdel Malik","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbadis.2022.166369_bb0210","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2337\/diacare.28.10.2345","article-title":"Improved clinical outcomes associated with metformin in patients with diabetes and heart failure","volume":"28","author":"Eurich","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2022.166369_bb0215","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/db16-0058","article-title":"The Na+\/Glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels","volume":"65","author":"Hawley","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2022.166369_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114132","article-title":"Downregulation of TLR4\/MyD88\/p38MAPK and JAK\/STAT pathway in RAW 264.7 cells by Alpinia galanga reveals its beneficial effects in inflammation","volume":"275","author":"George","year":"2021","journal-title":"J. Ethnopharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443922000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:07:37Z","timestamp":1760418457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443922000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0925443922000321"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166369","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myeloid differential protein-2 inhibition improves diabetic cardiomyopathy via p38MAPK inhibition and AMPK pathway activation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166369","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166369"}}